Highlights

[PHARMA] YoY Quarter Result on 2017-06-30 [#2]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 16-Aug-2017
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2017
Quarter 30-Jun-2017  [#2]
Profit Trend QoQ -     -49.69%    YoY -     -36.51%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 645,763 601,890 582,729 517,967 531,796 512,845 525,072 3.51%
  YoY % 7.29% 3.29% 12.50% -2.60% 3.70% -2.33% -
  Horiz. % 122.99% 114.63% 110.98% 98.65% 101.28% 97.67% 100.00%
PBT 14,326 12,481 11,970 10,150 21,487 25,056 24,622 -8.62%
  YoY % 14.78% 4.27% 17.93% -52.76% -14.24% 1.76% -
  Horiz. % 58.18% 50.69% 48.62% 41.22% 87.27% 101.76% 100.00%
Tax -4,719 -3,219 -6,204 -399 -5,846 -8,414 -8,665 -9.62%
  YoY % -46.60% 48.11% -1,454.89% 93.17% 30.52% 2.90% -
  Horiz. % 54.46% 37.15% 71.60% 4.60% 67.47% 97.10% 100.00%
NP 9,607 9,262 5,766 9,751 15,641 16,642 15,957 -8.10%
  YoY % 3.72% 60.63% -40.87% -37.66% -6.01% 4.29% -
  Horiz. % 60.21% 58.04% 36.13% 61.11% 98.02% 104.29% 100.00%
NP to SH 9,979 9,281 5,394 9,520 14,995 16,217 15,975 -7.54%
  YoY % 7.52% 72.06% -43.34% -36.51% -7.54% 1.51% -
  Horiz. % 62.47% 58.10% 33.77% 59.59% 93.87% 101.51% 100.00%
Tax Rate 32.94 % 25.79 % 51.83 % 3.93 % 27.21 % 33.58 % 35.19 % -1.09%
  YoY % 27.72% -50.24% 1,218.83% -85.56% -18.97% -4.58% -
  Horiz. % 93.61% 73.29% 147.29% 11.17% 77.32% 95.42% 100.00%
Total Cost 636,156 592,628 576,963 508,216 516,155 496,203 509,115 3.78%
  YoY % 7.34% 2.72% 13.53% -1.54% 4.02% -2.54% -
  Horiz. % 124.95% 116.40% 113.33% 99.82% 101.38% 97.46% 100.00%
Net Worth 357,891 518,564 519,642 542,147 524,177 528,477 502,293 -5.49%
  YoY % -30.98% -0.21% -4.15% 3.43% -0.81% 5.21% -
  Horiz. % 71.25% 103.24% 103.45% 107.93% 104.36% 105.21% 100.00%
Dividend
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Div 6,530 6,514 10,392 10,376 12,949 18,134 10,356 -7.39%
  YoY % 0.25% -37.32% 0.16% -19.87% -28.59% 75.10% -
  Horiz. % 63.06% 62.90% 100.35% 100.19% 125.03% 175.10% 100.00%
Div Payout % 65.45 % 70.19 % 192.67 % 108.99 % 86.36 % 111.82 % 64.83 % 0.16%
  YoY % -6.75% -63.57% 76.78% 26.20% -22.77% 72.48% -
  Horiz. % 100.96% 108.27% 297.19% 168.12% 133.21% 172.48% 100.00%
Equity
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Net Worth 357,891 518,564 519,642 542,147 524,177 528,477 502,293 -5.49%
  YoY % -30.98% -0.21% -4.15% 3.43% -0.81% 5.21% -
  Horiz. % 71.25% 103.24% 103.45% 107.93% 104.36% 105.21% 100.00%
NOSH 261,235 260,585 259,821 259,400 258,981 259,057 258,914 0.15%
  YoY % 0.25% 0.29% 0.16% 0.16% -0.03% 0.06% -
  Horiz. % 100.90% 100.65% 100.35% 100.19% 100.03% 100.06% 100.00%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 1.49 % 1.54 % 0.99 % 1.88 % 2.94 % 3.25 % 3.04 % -11.20%
  YoY % -3.25% 55.56% -47.34% -36.05% -9.54% 6.91% -
  Horiz. % 49.01% 50.66% 32.57% 61.84% 96.71% 106.91% 100.00%
ROE 2.79 % 1.79 % 1.04 % 1.76 % 2.86 % 3.07 % 3.18 % -2.16%
  YoY % 55.87% 72.12% -40.91% -38.46% -6.84% -3.46% -
  Horiz. % 87.74% 56.29% 32.70% 55.35% 89.94% 96.54% 100.00%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 247.20 230.98 224.28 199.68 205.34 197.97 202.80 3.35%
  YoY % 7.02% 2.99% 12.32% -2.76% 3.72% -2.38% -
  Horiz. % 121.89% 113.90% 110.59% 98.46% 101.25% 97.62% 100.00%
EPS 3.82 3.56 2.08 3.67 5.79 6.26 6.17 -7.67%
  YoY % 7.30% 71.15% -43.32% -36.61% -7.51% 1.46% -
  Horiz. % 61.91% 57.70% 33.71% 59.48% 93.84% 101.46% 100.00%
DPS 2.50 2.50 4.00 4.00 5.00 7.00 4.00 -7.53%
  YoY % 0.00% -37.50% 0.00% -20.00% -28.57% 75.00% -
  Horiz. % 62.50% 62.50% 100.00% 100.00% 125.00% 175.00% 100.00%
NAPS 1.3700 1.9900 2.0000 2.0900 2.0240 2.0400 1.9400 -5.63%
  YoY % -31.16% -0.50% -4.31% 3.26% -0.78% 5.15% -
  Horiz. % 70.62% 102.58% 103.09% 107.73% 104.33% 105.15% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 247.20 230.41 223.07 198.28 203.57 196.32 201.00 3.51%
  YoY % 7.29% 3.29% 12.50% -2.60% 3.69% -2.33% -
  Horiz. % 122.99% 114.63% 110.98% 98.65% 101.28% 97.67% 100.00%
EPS 3.82 3.55 2.06 3.64 5.74 6.21 6.12 -7.55%
  YoY % 7.61% 72.33% -43.41% -36.59% -7.57% 1.47% -
  Horiz. % 62.42% 58.01% 33.66% 59.48% 93.79% 101.47% 100.00%
DPS 2.50 2.49 3.98 3.97 4.96 6.94 3.96 -7.37%
  YoY % 0.40% -37.44% 0.25% -19.96% -28.53% 75.25% -
  Horiz. % 63.13% 62.88% 100.51% 100.25% 125.25% 175.25% 100.00%
NAPS 1.3700 1.9851 1.9892 2.0754 2.0066 2.0230 1.9228 -5.49%
  YoY % -30.99% -0.21% -4.15% 3.43% -0.81% 5.21% -
  Horiz. % 71.25% 103.24% 103.45% 107.94% 104.36% 105.21% 100.00%
Price Multiplier on Financial Quarter End Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 -
Price 2.2200 2.8400 2.8800 4.5800 5.5000 7.1300 4.6100 -
P/RPS 0.90 1.23 1.28 2.29 2.68 3.60 2.27 -14.28%
  YoY % -26.83% -3.91% -44.10% -14.55% -25.56% 58.59% -
  Horiz. % 39.65% 54.19% 56.39% 100.88% 118.06% 158.59% 100.00%
P/EPS 58.12 79.74 138.73 124.80 94.99 113.90 74.72 -4.10%
  YoY % -27.11% -42.52% 11.16% 31.38% -16.60% 52.44% -
  Horiz. % 77.78% 106.72% 185.67% 167.02% 127.13% 152.44% 100.00%
EY 1.72 1.25 0.72 0.80 1.05 0.88 1.34 4.24%
  YoY % 37.60% 73.61% -10.00% -23.81% 19.32% -34.33% -
  Horiz. % 128.36% 93.28% 53.73% 59.70% 78.36% 65.67% 100.00%
DY 1.13 0.88 1.39 0.87 0.91 0.98 0.87 4.45%
  YoY % 28.41% -36.69% 59.77% -4.40% -7.14% 12.64% -
  Horiz. % 129.89% 101.15% 159.77% 100.00% 104.60% 112.64% 100.00%
P/NAPS 1.62 1.43 1.44 2.19 2.72 3.50 2.38 -6.20%
  YoY % 13.29% -0.69% -34.25% -19.49% -22.29% 47.06% -
  Horiz. % 68.07% 60.08% 60.50% 92.02% 114.29% 147.06% 100.00%
Price Multiplier on Announcement Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 19/08/20 23/08/19 17/08/18 16/08/17 19/08/16 17/08/15 21/08/14 -
Price 4.4200 2.6600 3.1100 4.1900 5.6200 5.6500 4.6200 -
P/RPS 1.79 1.15 1.39 2.10 2.74 2.85 2.28 -3.95%
  YoY % 55.65% -17.27% -33.81% -23.36% -3.86% 25.00% -
  Horiz. % 78.51% 50.44% 60.96% 92.11% 120.18% 125.00% 100.00%
P/EPS 115.71 74.69 149.80 114.17 97.06 90.26 74.88 7.52%
  YoY % 54.92% -50.14% 31.21% 17.63% 7.53% 20.54% -
  Horiz. % 154.53% 99.75% 200.05% 152.47% 129.62% 120.54% 100.00%
EY 0.86 1.34 0.67 0.88 1.03 1.11 1.34 -7.12%
  YoY % -35.82% 100.00% -23.86% -14.56% -7.21% -17.16% -
  Horiz. % 64.18% 100.00% 50.00% 65.67% 76.87% 82.84% 100.00%
DY 0.57 0.94 1.29 0.95 0.89 1.24 0.87 -6.80%
  YoY % -39.36% -27.13% 35.79% 6.74% -28.23% 42.53% -
  Horiz. % 65.52% 108.05% 148.28% 109.20% 102.30% 142.53% 100.00%
P/NAPS 3.23 1.34 1.56 2.00 2.78 2.77 2.38 5.22%
  YoY % 141.04% -14.10% -22.00% -28.06% 0.36% 16.39% -
  Horiz. % 135.71% 56.30% 65.55% 84.03% 116.81% 116.39% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program
 
 

292  614  560  985 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 LCTITAN 2.13-0.27 
 SUPERMX-C1I 0.145-0.005 
 LUSTER 0.165-0.005 
 MAHSING 0.96-0.04 
 HWGB 0.78+0.065 
 DATAPRP 0.195-0.025 
 DGSB 0.225+0.01 
 KSTAR 0.43+0.06 
 MTOUCHE 0.045-0.01 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
6. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS